Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding.
Hepatol Int. 2023 Dec;17(6):1368-1377. doi: 10.1007/s12072-023-10579-w. Epub 2023 Sep 29.
Hepatol Int. 2023.
PMID: 37775724
Fibroblast-specific adipocyte enhancer binding protein 1 is a potential pathological trigger and prognostic marker for liver fibrosis independent of etiology.
Zhang W, Li YJ, Zhang N, Chen SY, Tong XF, Wang BQ, Huang T, You H, Chen W.
Zhang W, et al.
J Dig Dis. 2023 Oct;24(10):550-561. doi: 10.1111/1751-2980.13230. Epub 2023 Nov 7.
J Dig Dis. 2023.
PMID: 37776122
Item in Clipboard
Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial.
Wang B, Zhou J, Wu X, Sun Y, Li L, Li P, Li M, Jiang W, Xu M, Feng B, Xu X, Cheng J, Xie W, Han T, Wang X, Li H, Piao H, Zhao X, Chen S, Meng T, Guan Q, Meng F, Kong Y, Ou X, Jia J, You H.
Wang B, et al.
Am J Gastroenterol. 2024 Apr 1;119(4):700-711. doi: 10.14309/ajg.0000000000002569. Epub 2023 Nov 6.
Am J Gastroenterol. 2024.
PMID: 37929952
Clinical Trial.
Item in Clipboard
Cite
Cite